These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy]. Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H. Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950 [No Abstract] [Full Text] [Related]
6. [Value of dilazep in the treatment of coronary insufficiency. A randomized and double-blind study on subjects with stable, exertion angina]. Romano M, De Caprio L, Scarafile P, Carlomagno A, Meccariello P, Condorelli M. Minerva Cardioangiol; 1980 Nov; 28(7-8):489-94. PubMed ID: 7005711 [No Abstract] [Full Text] [Related]
7. [Review of the literature and report of experiments relating to the coronaroactive drug, hexobendine]. Marmo E, Caputi AP, Cataldi S. Minerva Cardioangiol; 1972 Oct; 20(10):571-81. PubMed ID: 4562623 [No Abstract] [Full Text] [Related]
16. [Treatment of therapy-resistant stenocardias associated with myocardial insufficiency using cormelian-digotab in a rehabilitation clinic]. Koeffler H. Fortschr Med; 1974 Dec 19; 92(35-36):1458-61. PubMed ID: 4435699 [No Abstract] [Full Text] [Related]